OxiGene (OXGN)

Add to Watchlists Create an Alert
2.20 -0.03  -1.35% NASDAQ Sep 16, 5:01PM BATS Real time Currency in USD
View Full Chart
OXGN Price Chart
View All Events

OXGN Events

Date Type Description
08/05/2014 16:30 EDT Misc OxiGene Inc Q2 2014 Earnings Conference Call
08/05/2014 Earnings OxiGene Inc Q2 2014 Earnings Results
06/10/2014 Misc Annual General Meeting for OxiGene Inc
05/06/2014 16:30 EDT Misc OxiGene Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings OxiGene Inc Q1 2014 Earnings Results
03/18/2014 16:30 EDT Misc OxiGene, Inc. Q4 2013 Earnings Conference Call
03/18/2014 Earnings OxiGene, Inc. Q4 2013 Earnings Results
11/12/2013 16:00 EDT Misc Oxigene Announces Third Quarter 2013 Earnings Conference Call and Webcast
11/12/2013 Earnings Third Quarter 2013 Financial Results
View All Performance Charts

OXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is up 3.29% over the last year vs S&P 500 Total Return up 20.89%, Achillion Pharmaceuticals up 62.84%, and Coronado Biosciences down 77.81%.

Get Quote for
Advertisement

Portfolio Strategies Featuring OXGN

Did OxiGene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OXGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oxigene.com
  • IR Website: http://investor.oxigene.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OxiGene, Inc., is a biopharmaceutical company. It is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer.

OXGN Excel Add-In Codes

  • Name: =YCI("OXGN","name")
  • Description: =YCI("OXGN","description")
  • Sector: =YCI("OXGN","sector")
  • Industry: =YCI("OXGN","industry")
  • Est. Current Fiscal Year End: =YCI("OXGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.